Work for Ocugen, Inc.?

Claim Your Profile

Ocugen, Inc. Logo Image

Ocugen, Inc.

Ocugen, Inc. Banner Image

About Ocugen, Inc.

11-50 Employees
Based in Malvern, Pennsylvania

Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases. Their breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug – “one to many” and their novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy.

Ticker:
OCGN
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol